Total Cancer Care eLetter: COVID-19 Edition

COVID cells graphic

Thank you for joining us in our mission to contribute to the prevention and cure of cancer by enrolling in the Total Cancer Care (TCC) study at Moffitt Cancer Center. The TCC study would not be possible without you!

COVID-19 has impacted all of us in different ways and I hope everyone continues to be safe. As the pandemic is still shaping the way we live, interact with others and access healthcare, Moffitt is interested to learn how our patients are impacted. This is our second newsletter, and in this edition, we are sharing examples of how Moffitt is studying COVID-19 in partnership with our patients, doctors and researchers. Additionally, we will share the results of the survey from our first eLetter that we sent out in early 2020.

We are eager to share how your participation in the TCC study is impacting COVID-19 research and future cancer care.

Please reach out to the TCC eLetter team at

Thank you,

Shelly Tworoger, PhD

Shelley S. Tworoger, PhD
Principal Investigator, Total Cancer Care